Technical Analysis for SAGE - Sage Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 144.68 2.21% 3.13
SAGE closed down 1.93 percent on Tuesday, November 12, 2019, on 1.56 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SAGE trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 2.21%
Fell Below 20 DMA Bearish 2.21%
Shooting Star Candlestick Bearish 2.21%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.21%
Wide Range Bar Range Expansion 2.21%
Doji - Bearish? Reversal 2.21%
Doji - Bullish? Reversal 2.21%
Earnings Movers Other 2.21%
Multiple of Ten Bearish Other 2.21%
Multiple of Ten Bullish Other 2.21%

Older signals for SAGE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat rare central nervous system disorders. The company's lead product candidate includes SAGE-547, an intravenous (IV) agent that is in Phase I/II clinical development as an adjunctive therapy for the treatment of super-refractory status epilepticus (SRSE). Its products in IND-enabling toxicology and safety pharmacology testing comprise SAGE-689, an adjunctive second-line therapy for the treatment of status epilepticus (SE); and SAGE-217, an IV monotherapy for the treatment of refractory status epilepticus, as well as an orally delivered maintenance therapeutic to prevent recurrent seizures in patients whose SE, RSE, or SRSE has resolved. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was founded in 2010 and is based in Cambridge, Massachusetts.
Chemistry Biopharmaceutical Physical Sciences Drugs Antidepressants Gabaa Receptor Positive Allosteric Modulators Adjunctive Therapy Anticonvulsants Neurosteroids
Is SAGE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 193.56
52 Week Low 79.88
Average Volume 367,766
200-Day Moving Average 161.4036
50-Day Moving Average 146.9416
20-Day Moving Average 141.746
10-Day Moving Average 141.609
Average True Range 6.3926
ADX 16.34
+DI 26.773
-DI 13.496
Chandelier Exit (Long, 3 ATRs ) 135.1422
Chandelier Exit (Short, 3 ATRs ) 153.3378
Upper Bollinger Band 147.2753
Lower Bollinger Band 136.2167
Percent B (%b) 0.48
BandWidth 7.801702
MACD Line -0.9619
MACD Signal Line -1.7049
MACD Histogram 0.7431
Fundamentals Value
Market Cap 5.29 Billion
Num Shares 37.4 Million
EPS -6.09
Price-to-Earnings (P/E) Ratio -23.24
Price-to-Sales 0.00
Price-to-Book 8.73
PEG Ratio 0.72
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 168.25
Resistance 3 (R3) 169.54 161.93 163.80
Resistance 2 (R2) 161.93 155.13 161.29 162.32
Resistance 1 (R1) 151.74 150.93 156.84 150.45 160.83
Pivot Point 144.13 144.13 146.68 143.49 144.13
Support 1 (S1) 133.94 137.33 139.04 132.65 122.27
Support 2 (S2) 126.33 133.13 125.69 120.78
Support 3 (S3) 116.14 126.33 119.30
Support 4 (S4) 114.85